Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

El Mustapha Bahassi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|May 12, 2011
Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functionsEl Mustapha Bahassi
Mutagenesis|August 24, 2014
Next-generation sequencing technologies: breaking the sound barrier of human geneticsEl Mustapha Bahassi, Peter J Stambrook
Pharmacology & Therapeutics|October 31, 2012
Targeting DNA repair mechanisms in cancerJohn M Furgason, El Mustapha Bahassi
Oncogene|January 11, 2005
The Plk3-Cdc25 circuitDavid L Myer, El Mustapha Bahassi, Peter J Stambrook
Cancer Medicine|May 31, 2017
Comparative molecular profiling of HPV-induced squamous cell carcinomasRobert F Koncar, Rebecca Feldman, El Mustapha Bahassi, et al.
Oncogene|February 18, 2004
Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocationEl Mustapha Bahassi, Robert F Hennigan, David L Myer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2020
Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH ProgramFrederick J Raal, El Mustapha Bahassi, Belinda Stevens, et al.
Mutation Research|February 17, 2006
Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damageEl Mustapha Bahassi, David L Myer, Richard J McKenney, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 25, 2019
Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid TumorsNagla Abdel Karim, Ola Gaber, Hashim M Aljohani, et al.
Oncotarget|May 16, 2015
ROS1 amplification mediates resistance to gefitinib in glioblastoma cellsHashim Aljohani, Robert F Koncar, Ahmad Zarzour, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Experimental Biology and Medicine (Maywood, N.J.)|May 12, 2011
Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functionsEl Mustapha Bahassi
Mutagenesis|August 24, 2014
Next-generation sequencing technologies: breaking the sound barrier of human geneticsEl Mustapha Bahassi, Peter J Stambrook
Pharmacology & Therapeutics|October 31, 2012
Targeting DNA repair mechanisms in cancerJohn M Furgason, El Mustapha Bahassi
Oncogene|January 11, 2005
The Plk3-Cdc25 circuitDavid L Myer, El Mustapha Bahassi, Peter J Stambrook
Cancer Medicine|May 31, 2017
Comparative molecular profiling of HPV-induced squamous cell carcinomasRobert F Koncar, Rebecca Feldman, El Mustapha Bahassi, et al.
Oncogene|February 18, 2004
Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocationEl Mustapha Bahassi, Robert F Hennigan, David L Myer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2020
Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH ProgramFrederick J Raal, El Mustapha Bahassi, Belinda Stevens, et al.
Mutation Research|February 17, 2006
Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damageEl Mustapha Bahassi, David L Myer, Richard J McKenney, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 25, 2019
Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid TumorsNagla Abdel Karim, Ola Gaber, Hashim M Aljohani, et al.
Oncotarget|May 16, 2015
ROS1 amplification mediates resistance to gefitinib in glioblastoma cellsHashim Aljohani, Robert F Koncar, Ahmad Zarzour, et al.
Pageof 3